Aclima Therapeutics Derive Private Limited
Pharmaceutical trading company incorporated in 2017, based in Uttar Pradesh.
2017 | Gautam Buddha Nagar, Uttar Pradesh (India) | Active
Aclima Therapeutics Derive Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 7.27%
- Profit Growth 6.80%
- Ebitda 10.62%
- Net Worth 34.90%
- Total Assets -3.03%
About Aclima Therapeutics Derive
Aclima Therapeutics Derive Private Limited (ATDPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 04 October 2017 (Seven years and five months 8 days old ). Its registered office is in Gautam Buddha Nagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Agrawal, Parul Agrawal, and Ritie Aggrawal serve as directors at the Company.
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909UP2017PTC097522
- Company No.
097522
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Pharma
What products or services does Aclima Therapeutics Derive Private Limited offer?
Aclima Therapeutics Derive Private Limited offers a wide range of products and services, including Hospital and Medical Furniture, Medical Trolley, Hospital Bed and Mattress, Wheel Chairs, Crutches and Walker, Walking Stick, Carts, Dollies & Trolleys, Metal Trolley, Hospital Furniture, Hospital Chair, Hospital Tables.
Aclima Therapeutics Derive Private Limited
Explore comprehensive data for Aclima Therapeutics Derive Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Aclima Therapeutics Derive?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Agrawal  | Director | 02-Dec-2020 | Current |
| Parul Agrawal | Director | 04-Oct-2017 | Current |
| Ritie Aggrawal | Director | 29-May-2018 | Current |
Financial Performance of Aclima Therapeutics Derive.
Aclima Therapeutics Derive Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.27% increase. The company also saw a slight improvement in profitability, with a 6.8% increase in profit. The company's net worth Soared by an impressive increase of 34.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aclima Therapeutics Derive?
In 2023, Aclima Therapeutics Derive had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aclima Therapeutics Derive?
Unlock and access historical data on people associated with Aclima Therapeutics Derive, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aclima Therapeutics Derive, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aclima Therapeutics Derive's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Aclima Therapeutics Derive
Recent activity within the organization
- Annual General Meeting
Aclima Therapeutics Derive Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Aclima Therapeutics Derive Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
- Director Appointment
Ashish Agrawal was appointed as a Director was appointed as a Director on 02 Dec 2020 & has been associated with this company since 4 years 3 months .
- Director Appointment
Ritie Aggrawal was appointed as a Director was appointed as a Director on 29 May 2018 & has been associated with this company since 6 years 9 months .
- Director Appointment
Parul Agrawal was appointed as a Director was appointed as a Director on 04 Oct 2017 & has been associated with this company since 7 years 5 months .
- Company Incorporation
Aclima Therapeutics Derive Private Limited was registered on 04 Oct 2017 with Roc Kanpur & aged 7 years 5 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Aclima Therapeutics Derive Private Limited?
Aclima Therapeutics Derive Private Limited was incorporated on 04 Oct 2017.
What is authorized share capital and paid-up capital of Aclima Therapeutics Derive Private Limited?
The authorized share capital of Aclima Therapeutics Derive Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Aclima Therapeutics Derive Private Limited?
Currently 3 directors are associated with Aclima Therapeutics Derive Private Limited.
- Ashish Agrawal
- Parul Agrawal
- Ritie Aggrawal
What is the registered address of Aclima Therapeutics Derive Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Aclima Therapeutics Derive Private Limited is L-701 Plumeria Garden Estate Near Achhar Village Omicron-3, Kasana India, Greater Noida, Uttar Pradesh, 201310.
What is the corporate identification number (CIN) and company number of Aclima Therapeutics Derive Private Limited?
The corporate identification number (CIN) of Aclima Therapeutics Derive Private Limited is U51909UP2017PTC097522 and the company number is 097522 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Aclima Therapeutics Derive Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Aclima Therapeutics Derive Private Limited has risen by 7.27%.
What change has been observed in the net worth of Aclima Therapeutics Derive Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Aclima Therapeutics Derive Private Limited has experienced an upsurge of 34.90%.
When was the last Balance Sheet of Aclima Therapeutics Derive Private Limited filed with the ROC?
The most recent Balance Sheet for Aclima Therapeutics Derive Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
HC
Harish ChandraDirector